Meta-Analysis: Crohn's Disease Exclusion Diet for Induction and Maintenance in Crohn's Disease
In brief
Crohn's disease exclusion diet induces remission in about 7 of 10 patients
A meta-analysis of 16 studies found that CDED-based regimens achieved clinical remission in roughly 69% of patients within 6-8 weeks, more than double the odds compared with standard diets. Response rates were high (about 83%), and remission was maintained in two-thirds of responders, though data on deeper disease markers remain sparse. Further randomized trials are needed to confirm long-term benefits.
- Journal
- Alimentary pharmacology & therapeutics (Q1)
- Published
- 12 July 2026
- Study design
- Systematic review / meta-analysis of RCTs
- Evidence level
- Level 1, High (CEBM 1a)
- Authors
- Gitika Batra, Aditi Shukla, Abhirup Chatterjee, Sanjay Chandnani, Arshdeep Singh, Dawesh P Yadav, et al.
- PMID
- 42437372
- DOI
- 10.1111/apt.70857
Why clinicians should know about it
- Picked for Gastroenterology (top studies of the week, 19 July 2026): Recent Gastroenterology research from a high-quartile journal.
- Picked for Hepatology (top studies of the week, 19 July 2026): Recent Hepatology research from a high-quartile journal.
- Picked for Histology (top studies of the week, 19 July 2026).
Abstract
BACKGROUND: There is a contemporary interest in dietary therapies for the treatment of inflammatory bowel disease. We performed a systematic review and meta-analysis to analyse the clinical effectiveness of the Crohn's disease exclusion diet (CDED) for Crohn's disease (CD). METHODS: We searched PubMed, Embase, and Scopus on 10th February 2025 to identify relevant studies using the terms 'Inflammatory bowel disease OR Crohn's disease' AND 'Crohn's disease exclusion diet'. We extracted information and estimated pooled rates for clinical response, clinical remission, and maintenance of remission with CDED alone, or with partial enteral nutrition (PEN), or exclusive enteral nutrition (EEN). We calculated the odds ratio for outcomes with CDED as compared to controls. Risk of Bias was estimated using RoB-2.0, ROBINS-I, and Joanna Briggs appraisal tools. RESULTS: Of the 508 titles, eventually 17 were included, and 16 studies provided quantitative data. The overall pooled rates for induction of clinical remission at 6-8 weeks with CDED-based interventions were 0.69 (95% CI: 0.65-0.74, I2 = 0.0%). On subgroup analysis, pooled clinical remission rates for CDED+PEN, CDED alone and EEN induction+CDED+PEN were 0.69 (95% CI: 0.63-0.75, I2 = 0.0%). 0.67 (95% CI: 0.57-0.76, I2 = 0.0%), 0.75 (95% CI: 0.61-0.85, I2 = 0.0%), respectively. The pooled rate of clinical response was 0.83 (0.74-0.89, I2 = 0%) at 6 weeks. The pooled rate of maintenance of remission was 0.64 (0.47-0.78, I2 = 73.5%). The overall odds of achieving clinical remission (2.58; 1.53-4.37, I2 = 0%) were higher compared to the control diet. On comparison with EEN, steroids and Mediterranean diet, the odds ratio to achieve clinical remission (6-12 weeks) was 2.05 (95% CI: 1.13-3.74, I2 = 0%), 17.33 (95% CI: 1.75-171), 3.95 (95% CI: 1.14-13.71, I2 = 0.0%), respectively. However, for clinical response (2.36; 95% CI: 0.62-9.00, I2 = 42.4%), the odds ratio was not significantly different. For maintenance of remission, the pooled odds ratio was 2.73 (95% CI: 1.3-5.74, I2 = 0%). Only limited data were available with respect to biochemical, endoscopic, transmural and histological outcomes. CONCLUSIONS: CDED-based dietary interventions appear to be efficacious for inducing remission in Crohn's disease. Well-designed randomised trials are required to further validate the use of CDED as a whole food approach in the induction and maintenance of remission in Crohn's Disease.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.